Skip to content

Effect of ultrasound guided intra-articular injection of corticosteroids and platelet-riched plasma in the treatment of rotator cuff tendinopathy

Comparison of the effect of ultrasound guided intra-articular injection of corticosteroids and platelet-riched plasma in the treatment of rotator cuff tendinopathy

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20221029056333N3
Enrollment
60
Registered
2023-04-28
Start date
2023-04-10
Completion date
Unknown
Last updated
2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rotator cuff tendinopathy. Rotator cuff tear or rupture, not specified as traumatic

Interventions

Intervention 1: Intervention group: For this group, PRP injection is performed. In this method, the patient had one PRP injection. In this group, 35 cc of venous blood was taken along with 5 cc of EDT

Sponsors

Babol University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 60 Years

Inclusion criteria

Inclusion criteria: Shoulder pain that lasts more than three months Tendinopathy and partial rupture of rotator cuff tendons MRI findings of tendinopathy or incomplete rotator cuff tear

Exclusion criteria

Exclusion criteria: Complete rupture of rotator cuff tendons History of shoulder surgery in the last 6 months Presence of rheumatological inflammatory diseases Shoulder instability is based on examinations The history of corticosteroid injection in the shoulder joint in the last 3 months History of PRP treatment in the last 6 months Dissatisfaction of patients

Design outcomes

Primary

MeasureTime frame
Pain. Timepoint: Before treatment and 1, 2, 3, and 6 months after the start of treatment. Method of measurement: Using the VAS scale & record severe pain intensity.;Shoulder range of motion. Timepoint: Before treatment and 1, 2, 3, and 6 months after the start of treatment. Method of measurement: By goniometer.

Secondary

MeasureTime frame
Patients' performance. Timepoint: Before treatment and 1, 2, 3, and 6 months after the start of treatment. Method of measurement: Disabilities of the Arm, Shoulder and Hand Outcome ?? DASH.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Mehrdad Mostafalo

Babol University of Medical Sciences

mostafa_mehrdad@yahoo.com+98 11 3225 6285

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026